Page last updated: 2024-09-03

y 27632 and mln 8237

y 27632 has been researched along with mln 8237 in 2 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(mln 8237)
Trials
(mln 8237)
Recent Studies (post-2010) (mln 8237)
1,924389124643236

Protein Interaction Comparison

ProteinTaxonomyy 27632 (IC50)mln 8237 (IC50)
Aurora kinase AHomo sapiens (human)0.0088
Tyrosine-protein kinase LckHomo sapiens (human)0.32
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)0.49
Ephrin type-A receptor 2Homo sapiens (human)0.048
Aurora kinase AMus musculus (house mouse)0.001
Aurora kinase BHomo sapiens (human)0.5416
Inner centromere proteinHomo sapiens (human)0.0011

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Jones, BC; Kelley, LC; Kozyreva, VK; Loskutov, YV; Marinak, KM; Pugacheva, EN; Smolkin, MB1

Other Studies

2 other study(ies) available for y 27632 and mln 8237

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
    Molecular cancer research : MCR, 2017, Volume: 15, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Amides; Animals; Aurora Kinase A; Azepines; Cell Line, Tumor; Cell Movement; Cortactin; Enzyme Inhibitors; Female; Humans; Mice, Inbred NOD; Molecular Targeted Therapy; Myosin Light Chains; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-vav; Pyridines; Pyrimidines; rac1 GTP-Binding Protein; rho-Associated Kinases; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2017